NO811973L - Ikke-glycosylert interferon. - Google Patents
Ikke-glycosylert interferon.Info
- Publication number
- NO811973L NO811973L NO811973A NO811973A NO811973L NO 811973 L NO811973 L NO 811973L NO 811973 A NO811973 A NO 811973A NO 811973 A NO811973 A NO 811973A NO 811973 L NO811973 L NO 811973L
- Authority
- NO
- Norway
- Prior art keywords
- interferon
- gene
- activator
- glycosylated human
- plg
- Prior art date
Links
- 108010050904 Interferons Proteins 0.000 title claims abstract description 45
- 102000014150 Interferons Human genes 0.000 title claims abstract description 36
- 229940079322 interferon Drugs 0.000 title claims description 32
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 28
- 210000002950 fibroblast Anatomy 0.000 claims abstract description 5
- 239000012190 activator Substances 0.000 claims description 20
- 108090000467 Interferon-beta Proteins 0.000 claims description 7
- 102000003996 Interferon-beta Human genes 0.000 claims description 6
- 230000009466 transformation Effects 0.000 claims description 6
- 210000000265 leukocyte Anatomy 0.000 claims description 5
- 102000006992 Interferon-alpha Human genes 0.000 claims description 4
- 108010047761 Interferon-alpha Proteins 0.000 claims description 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 4
- 230000000977 initiatory effect Effects 0.000 claims description 3
- 231100000252 nontoxic Toxicity 0.000 claims description 2
- 230000003000 nontoxic effect Effects 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 claims 2
- 229940047124 interferons Drugs 0.000 abstract description 4
- 239000013612 plasmid Substances 0.000 description 27
- 239000012634 fragment Substances 0.000 description 20
- 241000588724 Escherichia coli Species 0.000 description 8
- 238000000034 method Methods 0.000 description 6
- 229920001184 polypeptide Polymers 0.000 description 6
- 102000004196 processed proteins & peptides Human genes 0.000 description 6
- 108090000765 processed proteins & peptides Proteins 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 4
- 229960000723 ampicillin Drugs 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 3
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 3
- 108060002716 Exonuclease Proteins 0.000 description 2
- 239000003443 antiviral agent Substances 0.000 description 2
- 102000013165 exonuclease Human genes 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000005304 joining Methods 0.000 description 2
- 101150066555 lacZ gene Proteins 0.000 description 2
- 108010052418 (N-(2-((4-((2-((4-(9-acridinylamino)phenyl)amino)-2-oxoethyl)amino)-4-oxobutyl)amino)-1-(1H-imidazol-4-ylmethyl)-1-oxoethyl)-6-(((-2-aminoethyl)amino)methyl)-2-pyridinecarboxamidato) iron(1+) Proteins 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 101150111781 PGL1 gene Proteins 0.000 description 1
- 241000276498 Pollachius virens Species 0.000 description 1
- 241000711975 Vesicular stomatitis virus Species 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000000120 cytopathologic effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/565—IFN-beta
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
- C12N15/72—Expression systems using regulatory sequences derived from the lac-operon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Polyesters Or Polycarbonates (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15872180A | 1980-06-12 | 1980-06-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO811973L true NO811973L (no) | 1981-12-14 |
Family
ID=22569403
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO811973A NO811973L (no) | 1980-06-12 | 1981-06-11 | Ikke-glycosylert interferon. |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0042246B1 (ko) |
| JP (1) | JPS5777654A (ko) |
| KR (1) | KR830006421A (ko) |
| AT (1) | ATE25985T1 (ko) |
| AU (1) | AU544218B2 (ko) |
| DE (1) | DE3176011D1 (ko) |
| DK (1) | DK254681A (ko) |
| ES (2) | ES8300476A1 (ko) |
| IL (1) | IL63063A0 (ko) |
| NO (1) | NO811973L (ko) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK33181A (da) * | 1980-02-06 | 1981-08-07 | Searle & Co | Fremgangsmaade til fremstilling af et interferonlignende protein |
| FI88175C (fi) * | 1980-04-03 | 1993-04-13 | Biogen Inc | Rekombinant-dna-molekyler och foerfaranden foer framstaellning av polypeptider liknande humant -interferon |
| CH657141A5 (de) * | 1980-07-01 | 1986-08-15 | Hoffmann La Roche | Dns-sequenzen, rekombinante expressionsvektoren zur mikrobiellen herstellung von human-leukozyten-interferonen und transformierte mikroorganismen. |
| IL63916A0 (en) * | 1980-09-25 | 1981-12-31 | Genentech Inc | Microbial production of human fibroblast interferon |
| ZA816621B (en) * | 1980-09-25 | 1982-09-29 | Genentech Inc | Microbial production of human fibroblast interferon |
| IL63327A (en) * | 1981-07-16 | 1985-11-29 | Yeda Res & Dev | Production of interferon beta1 and alpha-phage recombinants for its production in host bacteria |
| IL66263A (en) * | 1981-08-10 | 1985-12-31 | Genex Corp | Expression vectors for introducing a gene into a procaryotic organism |
| GB2108510B (en) * | 1981-10-03 | 1984-12-12 | Ciba Geigy Ag | Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof |
| US4973479A (en) * | 1982-01-15 | 1990-11-27 | Cetus Corporation | Interferon-α61 |
| EP0098864A1 (en) * | 1982-01-15 | 1984-01-25 | Cetus Corporation | Interferon-alpha 74 |
| US4975276A (en) * | 1982-01-15 | 1990-12-04 | Cetus Corporation | Interferon-alpha 54 |
| US5098703A (en) * | 1982-01-15 | 1992-03-24 | Cetus Corporation | Interferon-alpha 76 |
| US6432677B1 (en) | 1982-03-08 | 2002-08-13 | Genentech, Inc. | Non-human animal interferons |
| IE54592B1 (en) * | 1982-03-08 | 1989-12-06 | Genentech Inc | Anumal interferons, processes involved in their production, compositions containing them, dna sequences coding therefor and espression vehicles containing such sequences and cells transformed thereby |
| US5827694A (en) * | 1982-03-08 | 1998-10-27 | Genentech, Inc. | DNA encoding non-human animal interferons, vectors and hosts therefor, and recombinant production of IFN polypeptides |
| US5702699A (en) * | 1982-09-23 | 1997-12-30 | Cetus Corporation | Process for the recovery of lipophilic proteins |
| US4992271A (en) * | 1982-09-23 | 1991-02-12 | Cetus Corporation | Formulation for lipophilic IL-2 proteins |
| US5643566A (en) * | 1982-09-23 | 1997-07-01 | Cetus Corporation | Formulation processes for lipophilic proteins |
| US4737462A (en) * | 1982-10-19 | 1988-04-12 | Cetus Corporation | Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β |
| US4588585A (en) * | 1982-10-19 | 1986-05-13 | Cetus Corporation | Human recombinant cysteine depleted interferon-β muteins |
| US5831023A (en) * | 1982-11-01 | 1998-11-03 | Genentech, Inc. | Recombinant animal interferon polypeptides |
| DE3247922A1 (de) * | 1982-12-24 | 1984-06-28 | Boehringer Ingelheim International GmbH, 6507 Ingelheim | Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten |
| JPS59172496A (ja) * | 1983-03-18 | 1984-09-29 | Kyowa Hakko Kogyo Co Ltd | モノクロ−ナル抗体 |
| US4518584A (en) * | 1983-04-15 | 1985-05-21 | Cetus Corporation | Human recombinant interleukin-2 muteins |
| IL71951A0 (en) * | 1983-06-01 | 1984-09-30 | Hoffmann La Roche | Polypeptides having interferon activity,their preparation and pharmaceutical compositions containing them |
| GB8412564D0 (en) * | 1984-05-17 | 1984-06-20 | Searle & Co | Structure and properties |
| SU1364343A1 (ru) * | 1984-07-13 | 1988-01-07 | Всесоюзный научно-исследовательский институт генетики и селекции промышленных микроорганизмов | Способ получени человеческого лейкоцитарного интерферона альфа-2 |
| FI90990C (fi) * | 1984-12-18 | 1994-04-25 | Boehringer Ingelheim Int | Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi |
| US5258298A (en) * | 1986-01-31 | 1993-11-02 | Genetics Institute, Inc. | Deletion and glycosylation mutant of human tissue plasminogen activator |
| US5837518A (en) * | 1986-01-31 | 1998-11-17 | Genetics Institute, Inc. | Thrombolytic proteins |
| WO1987004722A1 (en) * | 1986-01-31 | 1987-08-13 | Genetics Institute, Inc. | Novel thrombolytic proteins |
| FR2598430B1 (fr) * | 1986-05-06 | 1990-02-02 | Roussel Uclaf | Nouveaux vecteurs d'expression, leur procede d'obtention et leur application pour exprimer une proteine quelconque dans escherichia coli |
| US4839283A (en) * | 1986-12-30 | 1989-06-13 | Zymogenetics, Inc. | Method of expressing alpha-1-antitrypsin in yeast |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL58765A (en) * | 1979-11-21 | 1986-09-30 | Yeda Res & Dev | Process for the production of essentially pure messenger rna of human fibroblast interferon and process for the production of interferon beta |
| US4530901A (en) * | 1980-01-08 | 1985-07-23 | Biogen N.V. | Recombinant DNA molecules and their use in producing human interferon-like polypeptides |
| ES8308534A1 (es) * | 1980-01-08 | 1983-09-01 | Biogen Nv | Un metodo de producir un polipeptido que exhibe actividad inmunologica o biologica del interferon de leucocitos humanos. |
| GB2068970B (en) * | 1980-02-06 | 1983-06-22 | Searle & Co | Recombinant dna technique for the preparation of a protein resembling human interferon |
| DE3005897A1 (de) * | 1980-02-16 | 1981-09-03 | Hoechst Ag, 6000 Frankfurt | Genprodukt eines hoeheren organismus aus einem dieses gen enhtaltenden mikroorganismus |
| DE3005843A1 (de) * | 1980-02-16 | 1981-09-10 | Hoechst Ag, 6000 Frankfurt | Genprodukt eines hoeheren organismus aus einem dieses gen enthaltenden mikroorganismus |
| FI88175C (fi) * | 1980-04-03 | 1993-04-13 | Biogen Inc | Rekombinant-dna-molekyler och foerfaranden foer framstaellning av polypeptider liknande humant -interferon |
| CH657141A5 (de) * | 1980-07-01 | 1986-08-15 | Hoffmann La Roche | Dns-sequenzen, rekombinante expressionsvektoren zur mikrobiellen herstellung von human-leukozyten-interferonen und transformierte mikroorganismen. |
| IL63916A0 (en) * | 1980-09-25 | 1981-12-31 | Genentech Inc | Microbial production of human fibroblast interferon |
-
1981
- 1981-06-09 AT AT81302548T patent/ATE25985T1/de not_active IP Right Cessation
- 1981-06-09 EP EP81302548A patent/EP0042246B1/en not_active Expired
- 1981-06-09 DE DE8181302548T patent/DE3176011D1/de not_active Expired
- 1981-06-10 IL IL63063A patent/IL63063A0/xx unknown
- 1981-06-11 DK DK254681A patent/DK254681A/da not_active Application Discontinuation
- 1981-06-11 NO NO811973A patent/NO811973L/no unknown
- 1981-06-11 ES ES502970A patent/ES8300476A1/es not_active Expired
- 1981-06-12 KR KR1019810002120A patent/KR830006421A/ko unknown
- 1981-06-12 JP JP56089725A patent/JPS5777654A/ja active Pending
- 1981-06-12 AU AU71694/81A patent/AU544218B2/en not_active Withdrawn - After Issue
-
1982
- 1982-05-28 ES ES512619A patent/ES512619A0/es active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| ES502970A0 (es) | 1982-11-01 |
| KR830006421A (ko) | 1983-09-24 |
| ES8303919A1 (es) | 1983-02-16 |
| IL63063A0 (en) | 1981-09-13 |
| EP0042246A3 (en) | 1982-10-13 |
| EP0042246B1 (en) | 1987-03-18 |
| DE3176011D1 (en) | 1987-04-23 |
| AU544218B2 (en) | 1985-05-23 |
| ES512619A0 (es) | 1983-02-16 |
| EP0042246A2 (en) | 1981-12-23 |
| AU7169481A (en) | 1981-12-17 |
| JPS5777654A (en) | 1982-05-15 |
| DK254681A (da) | 1981-12-13 |
| ATE25985T1 (de) | 1987-04-15 |
| ES8300476A1 (es) | 1982-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO811973L (no) | Ikke-glycosylert interferon. | |
| AU601675B2 (en) | Purification, production and use of tumor necrosis factors | |
| EP0077670B1 (en) | Human immune interferon | |
| Gray et al. | Expression of human immune interferon cDNA in E. coli and monkey cells | |
| EP0319049B1 (en) | Growth hormone analogs, pharmaceutical and veterinary compositions containing said analogs and methods for production thereof | |
| US5460811A (en) | Mature human fibroblast interferon | |
| EP0275300B1 (en) | Recombinant vaccine | |
| ES2118756T5 (es) | Estimuladores de hematopoyesis de multiples dominios. | |
| DK173279B1 (da) | Rekombinant IL-6, fremgangsmåde til dets fremstilling og vektor til brug ved denne fremstilling samt dets anvendelse | |
| US4892743A (en) | Novel hybrid interferon species | |
| JP2852515B2 (ja) | ベクターウイルスおよびベクターウイルスを含む薬用組成物 | |
| US5582824A (en) | Recombinant DES-CYS-TYR-CYS human immune interferon | |
| EP1217891A4 (en) | THERAPEUTIC PROCEDURES AND COMPOSITIONS USING VIRUSES FROM THE RECOMBINANT FAMILY OF THE PARAMYXOVIRIDAE | |
| EP0238655A1 (en) | Human granulocyte-macrophage colony stimulating factor-like polypeptides and processes for producing them in high yields in microbial cells | |
| WO1989006695A1 (en) | Cleaved dimers of mullerian inhibiting substance-like polypeptides | |
| US5831023A (en) | Recombinant animal interferon polypeptides | |
| WO1999040198A3 (en) | Identification, production and use of staphylokinase derivatives with reduced immunogenicity and/or reduced clearance | |
| USH22H (en) | Synergistic effect of chemotherapeutic agents on beta-interferon | |
| US5637495A (en) | Plasmids for production of human growth hormone or polypeptide analog thereof, hosts containing the plasmids, products manufactured thereby, and related methods | |
| US5827694A (en) | DNA encoding non-human animal interferons, vectors and hosts therefor, and recombinant production of IFN polypeptides | |
| US5198361A (en) | Plasmids for production of met-asp-gln bovine growth hormone, hosts containing the plasmids, products manufactured thereby and related methods | |
| EP0318765A1 (en) | A modified gamma interferon dna sequences encoding it and process for producing it | |
| JPS61501430A (ja) | 修飾ガンマ・インタ−フェロン、そのｉｆｎをコ−ドするｄｎａ配列およびそのｉｆｎの生産方法 | |
| JPH08188597A (ja) | 変異型ヒト腫瘍壊死因子 | |
| PH26492A (en) | Recombinant human immune interferon |